Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate Concentrated Suspension for Cancer-associated Anorexia
NCT00637728Phase 3Terminated
- Sponsor
- Par Pharmaceutical
- Start
- Jun 2006
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of megestrol in cancer-associated anorexia, cachexia, sponsored by Par Pharmaceutical. Started Jun 2006; status: terminated.
02
Drugs
megestrol
03
Conditions
cancer-associated anorexiacachexia
Beyond the preview
Go deeper on NCT00637728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637728.